**Question:** All of the following are mediators of acute inflammation except

A. Histamine
B. Bradykinin
C. Thromboxane A2
D. Prostaglandin E2

**Correct Answer:** **Option D: Prostaglandin E2**

**Core Concept:** Acute inflammation is a key component of the immune response that involves the release of various mediators, including histamine, bradykinin, and thromboxane A2, which contribute to increased vascular permeability, vasodilation, and leukocyte recruitment. Prostaglandins, especially Prostaglandin E2 (PGE2), are also released during inflammation. However, unlike the other options, PGE2 primarily acts as an anti-inflammatory mediator, inhibiting the synthesis of other pro-inflammatory mediators and dampening the inflammatory response.

**Why the Correct Answer is Right:** Prostaglandin E2 (PGE2) is a potent pro-inflammatory mediator that plays a significant role in the immune response. It is synthesized from arachidonic acid through the action of enzymes like cyclooxygenase (COX), specifically COX-2. PGE2 contributes to increased vascular permeability, vasodilation, and recruitment of leukocytes, thereby supporting the inflammatory process.

**Why Each Wrong Option is Incorrect:**

A. Histamine: Histamine is a well-known mediator of acute inflammation, causing increased vascular permeability, vasodilation, and bronchoconstriction. It is released from mast cells and basophils upon tissue injury.

B. Bradykinin: Bradykinin is another key mediator of acute inflammation, promoting increased vascular permeability and causing edema. It is released from the kallikrein-kinin system during tissue injury.

C. Thromboxane A2: Thromboxane A2 (TxA2) is another lipid mediator involved in platelet aggregation, vasoconstriction, and vasodilation, supporting the inflammatory process. It is synthesized from arachidonic acid through the action of cyclooxygenase enzymes.

D. Prostaglandin E2 (PGE2): As explained earlier, PGE2 contributes to acute inflammation by promoting increased vascular permeability, vasodilation, and recruitment of leukocytes. It is synthesized from arachidonic acid through the action of cyclooxygenase enzymes.

**Clinical Pearls:**

Understanding the role of these inflammatory mediators in acute inflammation is essential for medical students and practitioners, as it helps in understanding the pathophysiology of various clinical conditions involving inflammation, such as asthma, bronchospasm, and systemic inflammatory response syndrome (SIRS).

**Clinical Scenario:**

Suppose a patient presents with symptoms of acute respiratory distress, bronchoconstriction, and increased vascular permeability. In that case, a clinician would consider various factors like asthma, bronchospasm, and systemic inflammatory response syndrome (SIRS). However, given the patient's clinical picture, the most likely mediator contributing to these symptoms is histamine, as it directly causes bronchoconstriction and increased vascular permeability, which leads to